Cerity Partners
AGIO icon

Cerity Partners’s Agios Pharmaceuticals AGIO Stock Holding History

Cerity Partners’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$751K Buy
+20,229
New +$614K ﹤0.01% 2173
2025
Q4 		– Sell
-6,439
Closed -$258K – 2877
2025
Q3 		$258K Sell
6,439
-350
-5% -$13.2K ﹤0.01% 2377
2025
Q2 		$226K Buy
+6,789
New +$206K ﹤0.01% 2288

Other funds holding AGIO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM

Cerity Partners's AGIO Position: Q2 2026 in Review

Cerity Partners opened a new position in Agios Pharmaceuticals (AGIO) in Q2 2026: 20,229 shares worth $751K. The stake represents ﹤0.01% of the portfolio and ranks #2173 among its holdings. This is a return to the name: Cerity Partners previously reported a position in AGIO as recently as Q3 2025.

Cerity Partners first reported a position in AGIO in Q2 2025 and has held it in 3 quarters since. 238 funds tracked by Wall St. Rank hold AGIO as of Q2 2026.

  • Cerity Partners held 20,229 shares of Agios Pharmaceuticals worth $751K as of Q2 2026.
  • Agios Pharmaceuticals was a new Cerity Partners position in Q2 2026.
  • Agios Pharmaceuticals made up ﹤0.01% of Cerity Partners's portfolio in Q2 2026, its #2173 holding.
  • Cerity Partners first reported a position in Agios Pharmaceuticals in Q2 2025 and has held it in 3 quarters since.
  • 238 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q2 2026.

Based on Cerity Partners's 13F filing for Q2 2026, filed 14 Aug 2026.